Cedar Crosse Research Center (Site 122) — Chicago, Illinois

Cedar Crosse Research Center (Site 122) is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cedar Crosse Research Center (Site 122) has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: Sagent Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedar Crosse Research Center (Site 122)?

Cedar Crosse Research Center (Site 122) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedar Crosse Research Center (Site 122) conducted?

Cedar Crosse Research Center (Site 122) has 1 clinical trials on record. Their work covers COVID-19.

Is Cedar Crosse Research Center (Site 122) accredited by Crixeo Health?

Cedar Crosse Research Center (Site 122) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cedar Crosse Research Center (Site 122)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.